Work

Nivolumab (Opdivo®) as single-agent first-line therapy for unresectable or metastatic melanoma

Year: 2015

Type: article

Authors: M. Ujeyl, A. Nachtnebel

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W350597403

FWCI: 0.152

Cites:

Cited by: 1

Related to: 10